• Phastar Net-Zero Target Approved by the Science Based Targets Initiative

    Oct 5, 2023, 08:24 by
    Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar commits to achieving Net-Zero Standard by 2035
    Full story
  • BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa

    Oct 4, 2023, 07:26 by
    Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.
    Full story
  • BioIVT to Host a Webinar on Optimizing Liquid Biopsy Research

    Oct 3, 2023, 08:38 by
    This webinar will discuss the importance of using standardized collection protocols and a diverse donor base to validate biomarkers and ensure their clinical utility.
    Full story
  • NCI To Conduct Massive Study To Evaluate Multi-Cancer Detection Assays

    Oct 3, 2023, 01:00 by User Not Found
    Clinical Research News | The importance of data has become apparent to everybody in recent years. We can now interrogate massive datasets to add value to clinical trials and utilize technology more efficiently to speed up time to market.
    Full story
  • Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

    Oct 2, 2023, 08:48 by
    Takara Bio Inc. has announced that it has entered into a License Agreement with non-profit/charity organization, Telethon.
    Full story
  • Emmes Introduces Telehealth Capabilities into Advantage eClinical

    Oct 2, 2023, 08:48 by
    Full story
  • DNAnexus-enabled UK Biobank Research Analysis Platform Surpasses 5,000 Users in Two Years

    Sep 29, 2023, 08:37 by
    The DNAnexus-enabled UK Biobank Research Analysis Platform community has grown to more than 5,000 users around the world.
    Full story
  • Tower Cold Chain Accelerates Growth with Two New Senior Appointments for The Americas

    Sep 29, 2023, 08:37 by
    Following the opening of its new Centre of Excellence facility to support further growth across the Americas, advanced temperature-controlled container specialist, Tower Cold Chain, has continued the expansion of its global team with the appointment of two senior leaders.
    Full story
  • X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

    Sep 29, 2023, 08:37 by
    X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through open science, announced that they have entered a collaboration aimed at creating new chemical tools to study human proteins.
    Full story
  • Alder Therapeutics set to redefine cell therapy development

    Sep 29, 2023, 08:37 by
    Alder Therapeutics is set to reshape the cell therapy sector with a novel, reduced-risk approach to cell therapy development and two promising cell therapy candidates for diseases with high unmet need.
    Full story
  • Creative Proteomics Introduces Mature Solutions for Membrane Protein Identification

    Sep 28, 2023, 07:25 by
    Full story
  • Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service

    Sep 28, 2023, 07:25 by
    Full story
  • Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment

    Sep 28, 2023, 07:25 by
    Full story
  • Creative Proteomics Launches State-of-the-Art Peptide Sequencing Service to Advance Proteomics Research

    Sep 28, 2023, 07:25 by
    Full story
  • Medidata Launches Diversity Program, HHS Extends Partnership to Develop Monoclonal Antibodies, Flatiron Renews FDA Collab

    Sep 28, 2023, 01:00 by User Not Found
    Clinical Research News | Flatiron Health renewed its collaboration with the Oncology Center of Excellence (OCE) of the United States Food and Drug Administration (FDA) to jointly develop and implement specific research projects; Medidata launched a program to improve diversity, equity, and inclusion in clinical trials; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.
    Full story
  • Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor

    Sep 27, 2023, 09:07 by
    Cytel Inc. has acquired the Berlin-based company co.faktor GmbH.
    Full story
  • Announcing Kivo GO: An intuitive DMS to accelerate speed-to-market for life sciences

    Sep 27, 2023, 09:07 by
    Kivo today introduced Kivo GO, a unified platform for emerging life sciences teams who need to work together efficiently across all functions while maintaining compliance and security.
    Full story
  • Discovery Park selects 13 start-ups to join Discovery Spark life science programme

    Sep 27, 2023, 09:07 by
    Thirteen life science start-ups have been accepted onto Discovery Park’s new business support programme and competition, Discovery Spark. The eight-week Discovery Spark programme will equip the early-stage companies with the necessary skills to catalyse their business growth plans and gives them the chance to win a business support package worth over £100,000.
    Full story
  • Follow the Money: NCI Awards Grant For Prostate Cancer Treatment Study, Recruiting Participants For Immunotherapy Drug Trials

    Sep 27, 2023, 01:00 by User Not Found
    Clinical Research News | The Icahn School of Medicine at Mount Sinai nets a grant to identify the best prostate cancer treatment for people with HIV; EverImmune will conduct a phase I/II clinical trial for its drug candidate Oncobax AK in patients undergoing immunotherapy; NIH establishes the Multi-Omics for Health and Disease Consortium to advance the generation and analysis of “multi-omic” data for human health research; more.
    Full story
  • Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation

    Sep 26, 2023, 09:29 by
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69 (current)
  • 70
  • »